Skip to main content

Bruker Value Stock - Dividend - Research Selection

Bruker

ISIN: US1167941087, WKN: 813534

Market price date: 06.11.2020
Market price: 46,46 USD




Bruker Fundamental data and company key figures of the share

Annual reports in USD
Key figures 29-03-2020
Cash flow
Net operating cash flow 213.400.000
Capital Expenditures -73.000.000
Free cash flow 140.400.000
Balance sheet
Total Equity 906.800.000
Liabilities & Shareholders equity 2.771.500.000
Income statement
Net income 197.200.000
Eps (diluted) 1,260
Diluted shares outstanding 156.508.000
Net sales/revenue 2.026.300.000

Fundamental ratios calculated on: 06-11-2020

Ratios
Key figures 06-11-2020
Cash flow
P/C 34,07
   
P/FC 51,79
Balance sheet
ROI7,12
ROE32,72
Income statement
P/E36,87
Div. Yield0,00%
P/B8,02
P/S3,59


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolBRKR
Market Capitalization7.271.361.536,00 USD
CountryUnited States
IndicesNASDAQ Comp.
SectorsIndustrial goods
Raw Data SourceUS GAAP in Millionen USD
Stock Split
Internetwww.bruker.com


Description of the company

Bruker Corporation manufactures and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates in two segments, Bruker Scientific Instruments, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry systems; infrared spectroscopy and radiological/nuclear detectors for chemical, biological, radiological, nuclear, and explosive detection in emergency response, homeland security, and defense applications; and research, analytical, and process analysis instruments and solutions based on infrared and Raman molecular spectroscopy technologies. The company also provides X-ray instruments, atomic force microscopy instrumentation, fluorescence optical microscopy instruments, analytical tools for electron microscopes and X-ray metrology, and defect-detection equipment for semiconductor process control, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments and spark optical emission spectroscopy systems. In addition, it offers superconducting and non-superconducting materials and devices. The company serves pharmaceutical, biotechnology and diagnostics, chemical, food and beverage, clinical, polymer, nanotechnology, semiconductor, and industrial companies; nonprofit laboratories; contract research organizations, academic institutions, medical schools, nonprofit or for-profit forensics, agriculture, food and beverage safety, environmental and clinical microbiology laboratories, hospitals, and government departments and agencies; and raw material manufacturers, and other businesses involved in materials analysis. It markets its products through direct sales forces, distributors, independent sales representatives, and other representatives. Bruker Corporation was founded in 1991 and is headquartered in Billerica, Massachusetts.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.bruker.com